Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disseminated Multi-system Sarcoidosis Mimicking Metastases on 18F-FDG PET/CT.

Literature DB >> 29889033

Disseminated Multi-system Sarcoidosis Mimicking Metastases on ¹⁸F-FDG PET/CT.

William Makis¹, Mark Palayew², Christopher Rush², Stephan Probst².

Abstract

A 60-year-old female with no significant medical history presented with hematuria. A computed tomography (CT) scan revealed extensive lymphadenopathy with hypodensities in the liver and spleen, and she was referred for an 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/CT (PET/CT) study to assess for malignancy of unknown primary. PET/CT revealed extensive 18F-FDG avid lymphadenopathy as well as innumerable intensely 18F-FDG avid lung, liver and splenic nodules, highly concerning for malignancy. A PET-guided bone marrow biopsy of the posterior superior iliac spine revealed several non-necrotizing, well-formed granulomas, consistent with sarcoidosis. The patient was managed conservatively and remained clinically well over the subsequent 9 years of follow-up.

Entities: Chemical Disease Gene Species

Keywords: 18F-fluorodeoxyglucose positron emission tomography.; Sarcoidosis; artifact; lymphadenopathy; metastases; mimic

Year: 2018 PMID： 29889033 PMCID： PMC5996599 DOI： 10.4274/mirt.29200

Source DB: PubMed Journal: Mol Imaging Radionucl Ther

12 in total

1. FDG PET in the clinical evaluation of sarcoidosis with bone lesions.

Authors: A Kobayashi; T Shinozaki; Y Shinjyo; K Kato; N Oriuchi; H Watanabe; K Takagishi
Journal: Ann Nucl Med Date: 2000-08 Impact factor: 2.668

2. FDG positron emission tomography of bone involvement in sarcoidosis.

Authors: Caroline Aberg; Fabio Ponzo; Bruce Raphael; Edward Amorosi; Victor Moran; Elissa Kramer
Journal: AJR Am J Roentgenol Date: 2004-04 Impact factor: 3.959

3. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions.

Authors: J Aoki; H Watanabe; T Shinozaki; K Takagishi; H Ishijima; N Oya; N Sato; T Inoue; K Endo
Journal: Radiology Date: 2001-06 Impact factor: 11.105

4. Chronic vascular graft infection with fistula to bone causing vertebral osteomyelitis, imaged with F-18 FDG PET/CT.

Authors: William Makis; Jerry Stern
Journal: Clin Nucl Med Date: 2010-10 Impact factor: 7.794

Review 5. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Authors: G J Cook; I Fogelman; M N Maisey
Journal: Semin Nucl Med Date: 1996-10 Impact factor: 4.446

Review 6. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Authors: Hongming Zhuang; Abass Alavi
Journal: Semin Nucl Med Date: 2002-01 Impact factor: 4.446

Review 7. FDG PET imaging in sarcoidosis.

Authors: Dragana Sobic-Saranovic; Vera Artiko; Vladimir Obradovic
Journal: Semin Nucl Med Date: 2013-11 Impact factor: 4.446

Disseminated Multi-system Sarcoidosis Mimicking Metastases on ¹⁸F-FDG PET/CT.

1. FDG PET in the clinical evaluation of sarcoidosis with bone lesions.

2. FDG positron emission tomography of bone involvement in sarcoidosis.

3. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions.

4. Chronic vascular graft infection with fistula to bone causing vertebral osteomyelitis, imaged with F-18 FDG PET/CT.

Review 5. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Review 6. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Review 7. FDG PET imaging in sarcoidosis.

8. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases.

9. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.

Review 10. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.

Review 1. The impact of infection and inflammation in oncologic ¹⁸F-FDG PET/CT imaging.

Review 2. Osseous manifestations of sarcoidosis.

Review 3. Acute Findings on FDG PET/CT: Key Imaging Features and How to Differentiate Them from Malignancy.

Disseminated Multi-system Sarcoidosis Mimicking Metastases on 18F-FDG PET/CT.

1. FDG PET in the clinical evaluation of sarcoidosis with bone lesions.

2. FDG positron emission tomography of bone involvement in sarcoidosis.

3. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions.

4. Chronic vascular graft infection with fistula to bone causing vertebral osteomyelitis, imaged with F-18 FDG PET/CT.

Review 5. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Review 6. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation.

Review 7. FDG PET imaging in sarcoidosis.

8. Nodular sarcoidosis of the liver and spleen: analysis of 32 cases.

9. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.

Review 10. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.

Review 1. The impact of infection and inflammation in oncologic 18F-FDG PET/CT imaging.

Review 2. Osseous manifestations of sarcoidosis.

Review 3. Acute Findings on FDG PET/CT: Key Imaging Features and How to Differentiate Them from Malignancy.

Disseminated Multi-system Sarcoidosis Mimicking Metastases on ¹⁸F-FDG PET/CT.

Review 1. The impact of infection and inflammation in oncologic ¹⁸F-FDG PET/CT imaging.